Possibly: The biggest predicting factors are the size of your tumor and the lymph node status. There are many helpful pieces of information online. Adjuvantonline.Com nccn.Org patient section. This is really a complex question because we now have oncotyping to tell us recurrence risk. I would ask your physician, and consider two opinions.
Answered 7/15/2013
5.5k views
Maybe: The benefits of chemotherapy are generally more dependent on the stage of the breast cancer rather than the receptor status. Er, pr, and her2-neu receptor status are not part of the staging criteria per se.
Answered 11/4/2012
5.5k views
A doctor has provided 1 answer
5 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
5 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question